Clinical Trials Browser

Phase 2 × Endometrial Neoplasms × inavolisib × Clear all

NCT07522697 2026-04-13

MITO END-4

Phase 2 Not yet recruiting

Hereditary Sensory and Autonomic Neuropathies, Endometrial Neoplasms